ReviewCurrent treatment options in oncology2026

Transforming a Roadblock into a Roadmap: Evolving HFSR Management From Adverse Event to Efficacy Biomarker.

Qian Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.